{
    "organizations": [],
    "uuid": "928b2c38be954174513cf614447c77b7ee1b0d8d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-follicum-phase-iia-study-approved/brief-follicum-phase-iia-study-approved-by-german-authority-idUSFWN1PX02M",
    "ord_in_thread": 0,
    "title": "BRIEF-Follicum: Phase IIa Study Approved By German Authority",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - FOLLICUM AB:\n* FOLLICUM PHASE IIA STUDY OF FOL-005 AGAINST HAIR LOSS APPROVED BY THE GERMAN MEDICINES AGENCY Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-07T15:45:00.000+02:00",
    "crawled": "2018-02-09T05:57:38.076+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "follicum",
        "ab",
        "follicum",
        "phase",
        "iia",
        "study",
        "hair",
        "loss",
        "approved",
        "german",
        "medicine",
        "agency",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}